PLRX · Pliant Therapeutics, Inc.
Market Cap
$68.73M
Shares
61.92M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-11 | — | |
| 10-Q | 2026-08-11 | 2026-06-30 | |
| 8-K | 2026-07-13 | 2026-07-09 | |
| 8-K | 2026-06-11 | — | |
| 10-Q | 2026-05-11 | 2026-03-31 | |
| 8-K | 2026-05-11 | — | |
| DEF 14A | 2026-04-22 | 2026-06-11 | |
| 8-K | 2026-04-17 | 2026-04-14 | |
| 8-K | 2026-03-30 | 2026-03-27 | |
| 10-K | 2026-03-11 | 2025-12-31 | |
| 8-K | 2026-03-11 | — | |
| 8-K | 2026-03-03 | — | |
| 8-K | 2025-12-16 | 2025-12-10 | |
| 8-K | 2025-12-08 | 2025-12-02 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-10-24 | 2025-10-20 | |
| 8-K | 2025-10-20 | 2025-10-14 | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-06-09 | 2025-06-05 | |
| 8-K | 2025-05-08 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-01 | — | |
| DEF 14A | 2025-04-23 | 2025-06-05 | |
| 8-K | 2025-03-13 | 2025-03-12 | |
| 8-K | 2025-03-03 | — | |
| 10-K | 2025-03-03 | 2024-12-31 | |
| 8-K | 2025-02-13 | — | |
| 8-K | 2025-02-10 | 2025-02-07 | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-09-27 | 2024-09-24 | |
| 8-K | 2024-08-07 | — | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-07-15 | — | |
| 8-K | 2024-06-14 | 2024-06-13 | |
| 8-K | 2024-05-14 | — | |
| 10-Q | 2024-05-06 | 2024-03-31 | |
| 8-K | 2024-05-06 | — | |
| DEF 14A | 2024-04-22 | 2023-12-31 | |
| 8-K | 2024-03-12 | 2024-03-11 | |
| 10-K | 2024-02-27 | 2023-12-31 | |
| 8-K | 2024-02-27 | — | |
| 8-K | 2024-02-05 | 2024-02-04 | |
| 8-K | 2023-11-09 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-10-03 | 2023-09-28 | |
| 8-K | 2023-09-26 | — | |
| 8-K | 2023-08-09 | — |
Showing 1–50 of 100 filings
Key facts
CIK
1746473
CUSIP
729139105
13F (30d)
84 filings
82 filers
Visit website
Investor relations